ArticlePDF Available

Rare presentation of Neurofibromatosis type1 with oral lesion

Authors:
  • PULLAREDDY DENTAL college
___________________________________________________ ____________________
_______________________________________________________________________________________
Department of Oral Medicine and Radiology, G Pullareddy Dental College, Kurnool, Andhra Pradesh
Copyright ©2017
Case Report
J Res Adv Dent 2016;6:1:18-22.
Rare Presentation of Neurofibromatosis Type I with Oral Lesion
Sairam V1* Gareema Raju P2 Praveen B3 Geethamalika MV4
1Professor and Head, Department of Oral Medicine and Radiology, G Pullareddy Dental College, Kurnool, Andhra Pradesh, India.
2PG Student, Department of Oral Medicine and Radiology, G Pullareddy Dental College, Kurnool, Andhra Pradesh, India.
3Reader, Department of Oral Medicine and Radiology, G Pullareddy Dental College, Kurnool, Andhra Pradesh, India.
4PG Student, Department of Oral Medicine and Radiology, G Pullareddy Dental College, Kurnool, Andhra Pradesh, India.
ABSTRACT
Background: The term neurofibromatoses is applied to a group of autosomal dominant disorders characterized
by neuroectodermal tumors involving several parts of the body. Among the eight types recognized,
Neurofibromatosis Type-1 is common without racial differences. It is chiefly characterized by six or more cafe´-
au-lait macules, two or more neurofibromas, freckling in the axillary or inguinal region and Lisch nodules over
the iris. Oral neurofibromas are extremely variable and rare, posing a diagnostic challenge to oral healthcare
providers. We present a rare case of Neurofibromatosis type- 1 with oral nuerofibromas (two) in the hard palate,
presence of cafe au lait (coffee with milk) pigmentation, discrete multiple nodules over different regions of the
body, two Lisch’s nodules of Iris. Clinical presentation of this patient is in accordance with the diagnostic criteria
given by the National Institutes of Health Criteria for Neurofibromatosis Type 1.
Keywords: Cafe´-Au-Lait Macules, Lisch’s Nodules, Oral Neurofibroma, Neurofibromatosis Type-1.
INTRODUCTION
Neurofibromatosis was described in 1882,
by German pathologist Friedrich Daniel Von
Recklinghausen, when he found a series of patients
with a combination of cutaneous lesions and tumors
of the peripheral and central nervous system. [1]
Neurofibromatosis type-1 is a neuro-cutaneous
autosomal dominant disorder, affecting all 3
germinal layers, having the potential to involve any
organ system.[2] It is caused by a mutation in the
NF1 gene on chromosome 17q11.2, which encodes
for the protein neurofibromin. [ 3] Neurofibroma
appears either as a solitary lesion or in a syndrome
or as von Recklinghausen's disease of the skin. [4]
Benign oral peripheral nerve tumors including
schwannoma, neurofibroma, nerve sheath myxoma,
palisded encapsulated neuroma etc, not only share a
neural origin, but also exhibit notable
heterogenecity in terms of microscopic and
pathogenetic aspects. [5]
Oral neurofibromas usually appear as
painless pedunculated or sessile nodules, with slow
growth pattern. Pain or paraesthesia may occur on
nerve compression. [6] Lisch nodules are pigmented
hamartomas, which appear as translucent brown-
pigmented spots on the iris. Lisch nodules are the
characteristic features of the affected individuals. [7]
In this paper we report a case of Neurofibromatosis
type 1 that received its diagnosis, after observation
of its significant presentation along the oral cavity
and its confirmation by histopathology.
CASE REPORT
A 39-year-old female patient reported to
the Department of Oral Medicine and Radiology
with a chief complaint of swellings along the roof of
the mouth since past 12 months. About 20 years
back the patient noticed a swelling along her lip ,
for which she underwent a surgery. Later she
developed similar swellings all over her body. The
swelling was not associated with any pain or any
19
Fig 1 & 2: Dermal Neurofibromas with café au
lait spots and pre axillary freckling.
Fig 3: Dermal Neurofibromas with café au lait
spots and pre axillary freckling.
Fig 4: Oral Neurofibromas along hard palate 11,21
and 11,12.
other relevant symptoms. Patient was not aware of
any such similar condition in her family. On
comprehensive general physical examination, the
patient was moderately built and nourished, calm,
coherent, able to respond well to the questions with
Fig 5: Gross Tissue Specimen.
Fig 6: H&E sections, showing parakeratinized
stratified squamous epithelium with underlying
connective showing loosely arranged collagen fibers
along with neural component with wavy nuclei.
no visual spatial difficulties. Vital signs were within
the normal range. Extra oral examination revealed
diffuse flat, oval to rounded brownish black
pigmentation with smooth borders measuring 0.5-
1.5cm. Non inflammatory purple nodular masses
(figure 1,2,3) of various sizes were present all over
her body including the chest, back, abdomen region.
On palpation these nodules were discrete, well
circumscribed, soft to firm in consistency,
nontender and compressible in nature. Diffuse
freckling in the axilla was appreciated.
Ophthalmological examination through slit lamp,
revealed the presence of pigmented hamartomatous
nodular aggregate along the iris resembling Lisch
nodules and early onset of cataract, with no signs of
glaucoma. Intraoral examination revealed two oval,
well defined sessile growth (figure 4) along the pre-
maxilla region of the hard palate, one growth in
relation to 11,21 and another in relation to 11,12.
The former and latter swellings measured about
0.25 × 0.25 and 0.5 × 0.5 cm in dimension. The
20
former being regular and the latter irregular in
shape, with mucosa over the growth appearing pink
in color. On palpation the swellings were sessile
with variable consistency, non-tender.
The patient was subjected to intraoral
periapical radiographic investigation of the anterior
teeth region, which showed no visible bony
involvement. Based on clinical presentation of
cutaneous pigmentation, generalized multiple
nodules, Lisch nodules in the eyes and intraoral
well-circumscribed tumor growth, a provisional
diagnosis of Oral Neurofibroma with
Neurofibromatosis type I was made. With the
patients consent, an excisional biopsy procedure
was performed under L.A (figure 5).The biopsy
specimen, stained with H&E, showed
parakeratinized stratified squamous epithelium
with underlying connective tissue along with focal
area of sub-epithelial hyalinization. The connective
tissue showed loosely arranged collagen fibers
along with neural component with wavy nuclei
dispersed all over the connective tissue with
moderate vascularity along with inflammatory cells
(figure 6), confirming the diagnosis of
Neurofibromatosis Type I.
Hence the based on the clinical as well as
histopathological features, a final diagnosis of
Neurofibromatosis Type I was given. Further review
could not be done, as patient did not turn up for
consecutive follow ups.
DISCUSSION
In 1882 German pathologist, Friedrich
Daniel von Recklinghausen, accurately described
the diverse findings of Neurofibromatosis as a
single entity. Since then, the condition is often
referred to as von Recklinghausen’s disease.
According to the most widely accepted
classification, there are four recognized forms of
neurofibromatosis:
1. von Recklinghausen’s neurofibromatosis (or
neurofibromatosis type 1 [NF-1] or peripheral
neurofibromatosis)
2. Bilateral acoustic neurofibromatosis (or
neurofibromatosis type 2 [NF-2] or central
neurofibromatosis)
3. Segmental neurofibromatosis
4. Cutaneous neurofibromatosis
Further the presence of three additional
forms: type 3 (mixed), type 4 (variant) and type 5
(late-onset), were suggested by Riccardi.[8]
Neurofibromatoses type1 disorder, presents with
signs and symptoms, which may begin at birth and
evolve over a life time, they may include both tumor
and non-tumor manifestations.[9] The following are
the diagnostic criteria laid down by National
Institute of Health Consensus Development
Conference, [ 10] which states at least four cardinal
features should be present to confirm the diagnoses
as Neurofibromatosis Type-1:
1. 6 or more café-au-lait macules larger than
5mm before puberty or 15mm after puberty
2. Freckling in the axillary or inguinal region
3. 2 or more neurofibromas or 1 plexiform
neurofibroma
4. 2 or more Lisch nodules
5. Optic Glioma
6. A distinctive osseous lesion such as sphenoid
dysplasia
7. Affected first-degree relative
This patient was evaluated initially by experts
in Oral Medicine at Dental Hospital with referral
consultations made to (Dermatologist,
Ophthalmologist, Neurologist, Obstetrician) for
comprehensive general evaluation. Our case was
found to fulfill the diagnostic criteria.
Neurofibroma’s are rare slow-growing benign
tumors, that are derived from the neural sheaths of
peripheral nerves. They comprise of Schwann cells,
fibroblast-like cells and intermediate cells.[11] In this
patient, multiple dermal neurofibromas involved
several regions of the body (figure 1).
Café au lait spots are hyperpigmented
maculae, with either smooth or irregular borders.
These maculae vary in their color and size, and
appear anywhere on the skin, with rare occurrence
on the face. [12] In Neurofibromatosis type I, inguinal
and axillary freckles (Crowe's sign) are seen
occuring, diffusely over the trunk, extremities,
upper eyelids, and base of the neck.[13] This patient
presented with both, the pigmentation and the
preaxillary freckling (figure 1, 2).
Lisch nodules are well defined, avascular,
smooth, regular, dome-shaped melanocytic
21
hamartomas, which are variable in color (yellow to
brown), size and number. They are located on the
surface of the iris, with their prevalence increasing
with age. [14]. In the head and neck region,
neurofibromas are frequently seen affecting scalp,
cheek, neck and oral cavity. In the oral cavity they
commonly occur on the tongue, lip, palate, gingiva,
major salivary glands, and maxillary bones. [14]
Prompt diagnosis of NF1 is essential, to prevent the
risk of development of complications such as
neurofibrosarcoma, pheochromocytoma, leukemia,
rhabdomyosarcoma, Wilms’ tumor, CNS tumors and
optic gliomas. [15]
CONFLICT OF INTEREST
No potential conflict of interest relevant to this
article was reported.
REFERENCES
1. Gerber PA, Antal AS, Neumann NJ, Homey B,
Matuschek C, Peiper M et al. Neurofibromatosis.
Eur J Med Res 2009; 14: 102-105.
2. Ghosh SK, Bandyopadhyay D, Ghosh A, Sarkar S.
Mucocutaneous Manifestations of
Neurofibromatosis Type-1: A Clinical Profile of
51 Indian Patients. J Turk Acad Dermatol 2008;
2 (4): 1-4.
3. Kanneppady SK, Lakshman AR, Kanneppady SS,
Banu V, Castelino RL. Neurofibromatosis Type 1
with Oral and Extra Oral Manifestations.
www.journalofdentofacialsciences.com 2013;
2(4): 25-28.
4. Depprich R, Singh DD, Reinecke P, Kubler NR,
Handschel J. Solitary submucous neurofibroma
of the mandible: review of the literature and
report of a rare case. Head & Face Medicine
2009; 5(24): 1-4.
5. Campos MS, Fontes A, Marocchio LS, Nunes FD,
Machado de souse SCO. Clinicopathologic and
immunohistochemical features of oral
neurofibroma. Acta Odontologica Scandinavica,
2012; 70: 577582.
6. Agrawal SM, Barodiya A, Agrawa MGl.
Neurofibromatosis involving hard palate: A rare
case report. Clinical Dentistry.2 0 1 2;6(12): 34-
37.
7. Munhoz EA, Cardoso CL, Tolentino ES,
Centurion BS, Goncales ES, Santana E et al. Von
Recklinghausen's disease - Diagnosis from oral
lesion. Neurofibromatosis I. Int. J.
Odontostomat. 2010; 4(2):179-183.
8. Dimitrova V, Yordanova I, Pavlova V, Valtchev V,
Gospodinov D, Parashkevova B et al. A case of
neurofibromatosis type 1. Journal of IMAB
2008; vol. 14: book 1 / 63-67.
9. Theos A, Korf BR. Pathophysiology of
Neurofibromatosis Type 1. Ann Intern Med.
2006;144(11):842-849.
10. Lopez-Jornet P, Gomez-Garcia E, Camacho-
Alonso F. Solitary oral neurofibroma. N Y State
Dent J 2010; 76: 54-55
11. Lykke E, Noergaard T, Rasmussen ER. Lingual
neurofibroma causing dysaesthesia of the
tongue. BMJ Case Rep 2013 ; 2013:
bcr2013010440. doi:10.1136/bcr-2013-
010440.
12. Garcia-de Marcos JA, Dean-Ferrer A, Alamillos-
Granados F, RuizMasera JJ, Garcia-de Marcos
MJ, Vidal-Jimenez A et al. Gingival neurofibroma
in a neurofibromatosis type 1 Gingival
neurofibroma in a neurofibromatosis type 1
patient. Med Oral Patol Oral Cir Bucal
2007;12:E287-91.
13. Ghalayani P, Saberi Z, Sardari F.
Neurofibromatosis type I (von
Recklinghausen's disease): A family case report
and literature review. Dent Res J (Isfahan).
2012 ; 9(4): 483–488.
14. Bharath TS, Krishna YR, Nalabolu
GR, Pasupuleti S, Surapaneni S, Ganta SB.
Neurofibroma of the palate. Case Rep
Dent. 2014;2014:898505. doi:
10.1155/2014/898505. Epub 2014 Apr 17.
15. Rupak S, Baby GG, Padiyath S, Kumar KKR.
Neurofibromatosis Type I with Oral
Manifestations. e-Journal Of Dentistry. 2012;
Vol 2 (1): 136-139.
22
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Neurofibroma is a benign tumour derived from the neural sheaths of peripheral nerves and composed of Schwann cells, fibroblast-like cells and intermediate cells. The usual clinical presentation of an oral neurofibroma is swelling. A 62-year-old woman was referred to our department of otorhinolaryngology with irritation and dysaesthesia of the lateral aspect of the tongue. The only finding was a slightly red area from which a biopsy was taken. The macroscopic findings observed by the surgeon were consistent with normal tongue tissue. The histopathological examination showed a small, rounded tumour closely approximated to an invagination of the surface epithelium and with a small lymphatic infiltrate. The tumour was a neurofibroma. A Schwannoma type B was considered but the presence of small nerves and positive neurofilament reaction favoured a neurofibroma. The patient had no other neurofibromas or skin lesions. At a 3-week follow-up visit all symptoms had resolved.
Article
Full-text available
Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance. Neurofibromatosis type I (NF-1), known as well as Recklinghausen's disease, is the most common type of the disease accounting 90% of the cases. We present a case of 52-year-old men with NF-1. The disease started in childhood with the appearance of multiple hyperpigmented skin macules. At the age of 46 a lot of cutaneous tumors appeared and started growing bigger all over the body surface. Because of a vision problem due to an upper left eyelid neurofibroma, the patient came for a clinical examination at the age of 52 years. INTRODUCTION Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance. At least 8 different clinical phenotypes of neurofibromatosis have been identified and are linked to at least two genetic disorders. Neuro-fibromatosis type I (NF-1) is the most common type of the disease accounting 90% of the cases, and is characterized by multiple café-au-lait spots and the occurrence of neurofibromas along peripheral nerves. CASE REPORT History A 52-year-old man with Neurofibromatosis type I is presented. The disease started in childhood with the appearance of multiple hyperpigmented skin macules. At the age of 46 a lot of cutaneous tumors appeared and started to increase in size all over the body surface especially on the left eyelid. Due to his psychic condition (the patient is mentally retarded after encephalitis in childhood) he has not consulted a doctor. The growth of the fibroma on the upper eyelid of the left eye had caused visual difficulties, which made him seek care.
Article
Full-text available
Objective: The purposes of this study were to assess clinical, histopathological and immunohistochemical features of 22 oral neurofibromas (NFs) and discuss with previously described literature, addressing the main aspects regarding the differential diagnosis. Materials and methods: Immunohistochemical reactions included S-100, CD34, GLUT-1, EMA, Ki-67, p53 and Collagen IV and histochemical reactions for Alcian blue. Results: Clinically, the preferential location was the maxillary bones, tongue and buccal mucosa. Microscopically, widely spread spindle-shaped cells with scant cytoplasm and elongated nuclei were observed. Immunostaining revealed that the tumor cells weakly expressed GLUT-1, Collagen IV, Ki-67 and p53. They were variably positive for CD34, S-100 protein and membrane epithelial antigen (EMA). Conclusions: The different types of nerve sheath cells observed in the present series reinforce the presence of heterogeneous population in NFs. The strong positivity for S-100 suggests that the lesions were more composed by S-100-positive Schwann cells than other cells. Besides, the high number of CD34-positive cells suggests that this marker can be useful for the differential diagnosis of NFs against PEN, traumatic neuromas and Schwannomas. Finally, the low immunostaining for p53 and Ki-67 may indicate that NFs massively composed by S-100-positive Schwann cells present low potential of aggressiveness and malignant transformation.
Article
Full-text available
Solitary neurofibroma is a rare benign non-odontogenic tumor. Particularly in the oral cavity, neurogenic tumors are rare, especially if they are malignant. Neurofibromas may present either as solitary lesions or as part of the generalised syndrome of neurofibromatosis or von Recklinghausen's disease of the skin. Clinically, oral neurofibromas usually appear as pediculated or sessile nodules, with slow growth and mostly without pain. The diagnosis can be confirmed by histological examination. Neurofibromas are immunopositive for the S-100 protein, indicating its neural origin. Treatment is surgical and the prognosis is excellent. For illustration a rare case of a solitary neurofibroma in the mandible is presented.
Article
Full-text available
Neurofibroma is a benign peripheral nerve sheath tumour. It is one of the most frequent tumours of neural origin and its presence is one of the clinical criteria for the diagnosis of type 1 neurofibromatosis (NF-I). Neurofibromatosis type 1 is an autosomal dominantly inherited disease due to an alteration in the long arm of chromosome 17. About 50% of NF-I patients have no family history of the disease. NF-I patients have skin lesions (cafe au lait spots and neurofibromas) as well as bone malformations and central nervous system tumours. Diagnosis is based on a series of clinical criteria. Gingival neurofibroma in NF-I is uncommon. Treatment of neurofibromas is surgical resection. The aim of this paper is to report a case of NF-I with gingival involvement and to review the literature.
Article
The term neurofibromatosis (NF) is used for a group of genetic disorders that primarily affect the cell growth of neural tissues. Neurofibromatosis type 1 (NF1), also known as von Recklinghausen's disease, is the most common type of NF, and accounts for about 90% of all cases. It is one of the most frequent human genetic diseases, with a prevalence of one case in 3,000 births. The expressivity of NF1 is extremely variable, with manifestations ranging from mild lesions to several complications and functional impairment. Oral manifestations can be found in almost 72% of the NF1 patients. The aim of this article is to report the NF1 in a family with different manifestations and to review the literature.
Article
Neurofibroma is a benign tumor of the peripheral nerve sheath characterized by proliferation of Schwann's cells, perineural cells and endoneurial fibroblasts. The tumor occurs most often in the head and neck regions. We describe the occurrence of an isolated neurofibroma in the upper lip of a 14-year-old girl.
Article
Summary of Neurofibromatoses* Disorder Prevalence Features Gene Protein/Function NF1 1:3500 people Refer to Tables 1 and 3 NF1 Neurofibromin/GAPNF2 1:40 000 people Vestibular and other schwannoma, meningioma,ependymoma, glioma, neurofibroma, cataract NF2 Merlin or schwannomin/cytoskeletalproteinSchwannomatosis Unknown Schwannoma Unknown Unknown * GAP guanosine triphosphatase (GTPase)–activating protein; NF1 neurofibromatosis type 1; NF2 neurofibromatosis type 2. Figure 4. Ras signaling pathway. Binding of ligand to membrane tyrosine kinase receptor results in con-version of Ras–guanosine diphosphate ( GDP ) to Ras–guanosine triphos-phate ( GTP ). This leads to a cascade of activation of other proteins(“effector pathways”), which eventually results in activation of transcrip-tion of specific genes. Shc, Grb2, SoS, Raf, Mek, and Erk are additionalproteins in the Ras signal transduction pathway. NF1 neurofibroma-tosis type 1; P phosphate Review Pathophysiology of Neurofibromatosis Type 1
Gingival neurofibroma in a neurofibromatosis type 1 Gingival neurofibroma in a neurofibromatosis type 1 patient
  • Ja Garcia-De Marcos
  • A Dean-Ferrer
  • F Alamillosgranados
  • Jj Ruizmasera
  • Mj Garcia-De Marcos
  • A Vidal-Jimenez
Garcia-de Marcos JA, Dean-Ferrer A, AlamillosGranados F, RuizMasera JJ, Garcia-de Marcos MJ, Vidal-Jimenez A et al. Gingival neurofibroma in a neurofibromatosis type 1 Gingival neurofibroma in a neurofibromatosis type 1 patient. Med Oral Patol Oral Cir Bucal 2007;12:E287-91.